non-small cell lung cancer

Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
Yahoo/Reuters
Mon, 05/19/25 - 10:33 pm
Pfizer
China
3SBio
cancer
oncology
non-small cell lung cancer
metastatic colorectal cancer
First subject dosed in Revolution Medicines’ Phase III NSCLC treatment trial
Clinical Trials Arena
Thu, 05/15/25 - 10:59 am
Revolution Medicines
RMC-6236
clinical trials
non-small cell lung cancer
Merck lays out subcutaneous Keytruda data in lung cancer amid patent brawl with Halozyme
Fierce Pharma
Thu, 03/27/25 - 11:39 am
Merck
Keytruda
non-small cell lung cancer
This Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This Year
Motley Fool
Thu, 03/13/25 - 11:32 am
Summit Therapeutics
ivonescimab
cancer
non-small cell lung cancer
Bristol Myers Squibb notches overall survival win with Opdivo in preoperative NSCLC
Fierce Pharma
Thu, 02/20/25 - 11:38 am
Bristol Myers Squibb
Opdivo
non-small cell lung cancer
clinical trials
Xcovery wins FDA approval for ALK inhibitor in NSCLC
First Word Pharma
Thu, 12/19/24 - 09:18 pm
Xcovery
FDA
Ensacove
ALK inhibitors
non-small cell lung cancer
Moderna and Merck begin trial of mRNA-4157 and Keytruda combination for lung cancer
Clinical Trials Arena
Tue, 10/29/24 - 11:43 am
Moderna Therapeutics
Merck
clinical trials
vaccines
Keytruda
mRNA-4157
non-small cell lung cancer
Novocure wins FDA approval for electric field device in lung cancer
BioPharma Dive
Wed, 10/16/24 - 05:22 pm
Novocure
Optune Luna
Medtech
FDA
non-small cell lung cancer
Ivonescimab Looking to Rival Merck’s Keytruda in NSCLC with Phase III Trial Enrollment Complete
Xtalks
Thu, 10/10/24 - 10:02 am
Summit Therapeutics
ivonescimab
non-small cell lung cancer
clinical trials
Merck
Keytruda
BMS' Opdivo joins the perioperative lung cancer treatment ring with key FDA approval
Fierce Pharma
Thu, 10/3/24 - 10:25 pm
Bristol Myers Squibb
Opdivo
FDA
non-small cell lung cancer
AbbVie seeks FDA approval for non-small cell lung cancer treatment
Pharmaceutical Business Review
Mon, 09/30/24 - 09:45 am
AbbVie
FDA
Teliso-V
non-small cell lung cancer
AZ gets sought-after lung cancer approval for Tagrisso
Pharmaphorum
Thu, 09/26/24 - 10:59 am
AstraZeneca
Tagrisso
FDA
non-small cell lung cancer
Keytruda beaten by Summit’s bispecific in NSCLC
Clinical Trials Arena
Fri, 09/20/24 - 11:15 am
Summit Therapeutics
Akeso
Merck
clinical trials
ivonescimab
Keytruda
non-small cell lung cancer
Daiichi Sankyo-Merck's 'guided-missile' cancer drug meets main goal in late-stage trial
Reuters
Tue, 09/17/24 - 09:51 am
Daiichi Sankyo
Merck
patritumab deruxtecan
clinical trials
non-small cell lung cancer
Pfizer pushing BRAF lung cancer mutation testing to grow market for Braftovi
Reuters
Sun, 09/15/24 - 06:23 pm
Pfizer
Baraftovi
BRAF inhibitor
non-small cell lung cancer
Boehringer Ingelheim reports positive results from trial of HER2 lung cancer drug
Clinical Trials Arena
Tue, 09/10/24 - 08:35 am
Boehringer Ingelheim
clinical trials
zongertinib
non-small cell lung cancer
Gilead's Trodelvy triplet underwhelms, but bolsters company's phase 3 lung cancer design
Fierce Pharma
Mon, 09/9/24 - 07:12 pm
Gilead Sciences
Trodelvy
non-small cell lung cancer
J&J bolsters Rybrevant-Lazcluze's case against AZ's Tagrisso with survival analysis
Fierce Pharma
Sun, 09/8/24 - 11:38 pm
JNJ
Rybrevant
Lazcluze
AstraZeneca
Tagrisso
non-small cell lung cancer
Summit lung cancer drug shows ‘striking’ benefit over Keytruda
BioPharma Dive
Sun, 09/8/24 - 11:32 pm
Summit Therapeutics
Merck
Keytruda
clinical trials
non-small cell lung cancer
Merck’s Keytruda flunks pivotal studies in early-stage lung and skin cancers
Fierce Pharma
Thu, 08/29/24 - 11:15 am
Merck
Keytruda
non-small cell lung cancer
clinical trials
cutaneous squamous cell carcinoma

Pages